Literature DB >> 6319764

Nucleotide sequence analysis of the long terminal repeat of integrated bovine leukemia provirus DNA and of adjacent viral and host sequences.

D Couez, J Deschamps, R Kettmann, R M Stephens, R V Gilden, A Burny.   

Abstract

The nucleotide sequence of the 3' long terminal repeat and adjacent viral and host sequences was determined for a bovine leukemia provirus cloned from a bovine tumor. The long terminal repeat was found to comprise 535 nucleotides and to harbor at both ends an imperfect inverted repeat of 7 bases. Promoter-like sequences (Hogness box and CAT box), an mRNA capping site, and a core enhancer-related sequence were tentatively located. No kinship was detected between this bovine leukemia proviral fragment and other retroviral long terminal repeats, including that of human T-cell leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319764      PMCID: PMC255509     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas.

Authors:  G S Payne; J M Bishop; H E Varmus
Journal:  Nature       Date:  1982-01-21       Impact factor: 49.962

2.  Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure.

Authors:  M Seiki; S Hattori; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Nucleotide sequence analysis of the long terminal repeat of integrated simian sarcoma virus: evolutionary relationship with other mammalian retroviral long terminal repeats.

Authors:  S G Devare; E P Reddy; J D Law; S A Aaronson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

4.  Nucleotide sequence analysis of the long terminal repeat of avian myeloblastosis virus and adjacent host sequences.

Authors:  K E Rushlow; J A Lautenberger; E P Reddy; L M Souza; M A Baluda; J G Chirikjian; T S Papas
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.

Authors:  C Van Beveren; E Rands; S K Chattopadhyay; D R Lowy; I M Verma
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

6.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

7.  At least two regions of the viral genome determine the oncogenic potential of avian leukosis viruses.

Authors:  H L Robinson; B M Blais; P N Tsichlis; J M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus.

Authors:  S Oroszlan; M G Sarngadharan; T D Copeland; V S Kalyanaraman; R V Gilden; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Structure of the baboon endogenous virus genome: nucleotide sequences of the long terminal repeat.

Authors:  T Tamura; M Noda; T Takano
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

10.  Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function.

Authors:  J Sorge; S H Hughes
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

View more
  11 in total

1.  In vitro methylation inhibits the promotor activity of a cloned intracisternal A-particle LTR.

Authors:  A Feenstra; J Fewell; K Lueders; E Kuff
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

2.  Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.

Authors:  C A Rosen; J G Sodroski; R Kettman; W A Haseltine
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections.

Authors:  D M Lagarias; K Radke
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.

Authors:  D Milan; J F Nicolas
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression.

Authors:  V Kiermer; C Van Lint; D Briclet; C Vanhulle; R Kettmann; E Verdin; A Burny; L Droogmans
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Bovine leukemia virus: unique structural features of its long terminal repeats and its evolutionary relationship to human T-cell leukemia virus.

Authors:  N Sagata; T Yasunaga; Y Ogawa; J Tsuzuku-Kawamura; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus.

Authors:  J Sodroski; M Trus; D Perkins; R Patarca; F Wong-Staal; E Gelmann; R Gallo; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Nucleotide sequence analysis of squirrel monkey retrovirus reveals a novel primer-binding site for tRNALys1,2.

Authors:  I M Chiu; S F Skuntz
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein.

Authors:  J G Sodroski; W C Goh; C A Rosen; S Z Salahuddin; A Aldovini; G Franchini; F Wong-Staal; R C Gallo; K Sugamura; Y Hinuma
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.